[{"NetIncomeLoss_1_Q1_USD":-183659000.0,"OperatingLeaseLiability_0_Q1_USD":23811000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"MarketableSecuritiesCurrent_0_Q1_USD":458237000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":40579000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":79219000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":69398000.0,"RestrictedCashCurrent_0_Q1_USD":1552000.0,"InterestPaidNet_1_Q1_USD":6893000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1620000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-146765000.0,"Depreciation_1_Q1_USD":282000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":4811000.0,"AssetsCurrent_0_Q1_USD":773625000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":-17084000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":171281000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":24334000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2588000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":386152000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":79000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":5480000.0,"Liabilities_0_Q1_USD":758471000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":265435000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":84012000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":29177000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":5819000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":25000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1611000.0,"PrepaidExpenseCurrent_0_Q1_USD":17203000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-42802000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1544000.0,"CommonStockValue_0_Q1_USD":8000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":162258000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":4242000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1632000.0,"RestrictedCash_0_Q1_USD":1552000.0,"InvestmentIncomeNonoperating_1_Q1_USD":134000.0,"OtherAssetsCurrent_0_Q1_USD":31198000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":-956000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-185162000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-4170000.0,"OtherAssetsNoncurrent_0_Q1_USD":6909000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":19909000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-11946000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"Assets_0_Q1_USD":810129000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-300058000.0,"CommonStockSharesOutstanding_0_Q1_shares":80438000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-1503000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":956000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16439000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-1582000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-153314000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":5415000.0,"LiabilitiesCurrent_0_Q1_USD":83670000.0,"AccountsPayableCurrent_0_Q1_USD":4158000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":266987000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2588000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":24955000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0776,"AdditionalPaidInCapital_0_Q1_USD":1147263000.0,"OperatingLeasePayments_1_Q1_USD":1588000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7077000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1093993000.0,"CommonStockSharesIssued_0_Q1_shares":80438000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":484000.0,"LitigationSettlementAmountAwardedToOtherParty_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-1503000.0,"ShareBasedCompensation_1_Q1_USD":16439000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":22518000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"DebtConversionConvertedInstrumentAmount1_1_Q1_USD":126129000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":5366000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-124591000.0,"PreferredStockValue_0_Q1_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"OperatingLeaseCost_1_Q1_USD":1300000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":810129000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":360000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3902000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":5675000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.32,"ProfitLoss_1_Q1_USD":-183659000.0,"StockholdersEquity_0_Q1_USD":51658000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4204000.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210428"}]